Theprubicin

Known as: Aventis brand of pirarubicin, Theprubicine, Théprubicine 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1984-2017
0119842017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
RATIONALE Malignant myopericytoma is extremely rare, with a few cases described in the English literature. PATIENT CONCERNS… (More)
Is this relevant?
2015
2015
The aim of the present study was to investigate the underlying mechanisms of methotrexate (MTX) resistance in the human… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table I
Is this relevant?
2015
2015
A 39-year-old female presented to The First Affiliated Hospital of Jishou University (Jishou, Hunan) with a fever of unknown… (More)
Is this relevant?
2014
2014
Osteosarcoma is a primary malignant tumor in adolescents, associated with high mortality and morbidity. The high-dose… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2010
2010
The collagen gel droplet embedded culture-drug sensitivity test (CD-DST) is an anticancer drug sensitivity test developed about… (More)
Is this relevant?
1990
1990
Drug-induced myelotoxicity is usually the dose-limiting factor of treatment of malignant tumors with cytostatic drugs… (More)
  • figure 1
Is this relevant?
1984
1984
We tested the effect of Bisantrene (BS) and Theprubicin (THP-ADR) on cell growth of a human pancreatic carcinoma cell line (MIA… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • table 1
Is this relevant?